IPOPLUS

2,272

-5.8 -0.25%

18 Jun 2026

NSE Listed · Pharmaceuticals

Lupin Limited (LUPIN)

Volume: 12,983Avg Vol 1W: 1,94,223Avg Vol 1M: 4,13,50652W Range:1,836.82,494
₹2,272 0.25%
Key Ratios
Updated 5h ago
Market Cap₹1,04,830 Cr
Current Price₹2,272
Previous Close₹2,277.8
High / Low (52w)₹2,494 / ₹1,836.8
Volume12,983
Avg Vol (1W)1,94,223
Avg Vol (1M)4,13,506
Stock P/E28.2
Book Value₹490.99
Dividend Yield0.79%
ROE23.76%
ROA13.96%
Revenue (TTM)
Revenue Growth13.48%
Profit Margin19.4%
Total Debt₹1,766 Cr
Shares Outstanding46 Cr
Face Value₹2
EPS (TTM)₹34.83
P/B4.59
Debt / Equity0.29
50 DMA₹2,265.63
200 DMA₹2,270.55
Day change-0.25%
Price Chart
2,272 17.05% · 1Y
2462192134.7L
2025-10-21
2026-06-16

20-day avg volume: 3.8L shares

Pros
  • Healthy return on equity of 23.8%.
  • Company is almost debt-free.
  • Revenue grew 14% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹7,475 Cr₹7,168 Cr₹7,048 Cr₹6,268 Cr₹5,667 Cr₹5,768 Cr₹5,673 Cr₹5,600 Cr₹4,961 Cr₹5,197 Cr₹5,039 Cr₹4,814 Cr₹4,430 Cr₹4,322 Cr₹4,146 Cr₹3,744 Cr₹3,883 Cr₹4,161 Cr₹4,091 Cr₹4,270 Cr₹3,783 Cr₹4,017 Cr₹3,835 Cr₹3,528 Cr₹3,846 Cr
EBITDA₹2,180 Cr₹2,064 Cr₹2,115 Cr₹1,507 Cr₹985 Cr₹1,138 Cr₹1,126 Cr₹1,061 Cr₹569 Cr₹810 Cr₹710 Cr₹644 Cr₹351 Cr₹330 Cr₹264 Cr₹45 Cr₹-44 Cr₹200 Cr₹-2,170 Cr₹784 Cr₹550 Cr₹556 Cr₹393 Cr₹317 Cr₹520 Cr
Net Profit₹1,460 Cr₹1,176 Cr₹1,478 Cr₹1,219 Cr₹773 Cr₹855 Cr₹853 Cr₹801 Cr₹359 Cr₹613 Cr₹490 Cr₹452 Cr₹236 Cr₹153 Cr₹130 Cr₹-89 Cr₹-518 Cr₹546 Cr₹-2,098 Cr₹542 Cr₹460 Cr₹438 Cr₹211 Cr₹107 Cr₹390 Cr
EPS34.7525.6732.2826.6216.8718.6918.6417.527.8613.4110.729.95.163.362.85-1.96-11.411.98-46.2211.9110.119.634.642.358.61
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹22,910 Cr₹20,142 Cr₹16,793 Cr₹16,616 Cr₹15,299 Cr₹15,859 Cr
EBITDA₹4,310 Cr₹2,734 Cr₹991 Cr₹-1,230 Cr₹1,816 Cr₹1,868 Cr
Net Profit₹3,282 Cr₹1,914 Cr₹430 Cr₹-1,528 Cr₹1,217 Cr₹-269 Cr
EPS71.6941.879.41-33.6526.72-5.95
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹29,205 Cr₹23,997 Cr₹22,956 Cr₹21,821 Cr₹23,610 Cr₹24,984 Cr
Total Liabilities₹11,911 Cr₹9,624 Cr₹10,413 Cr₹9,599 Cr₹9,752 Cr₹12,403 Cr
Equity₹17,294 Cr₹14,373 Cr₹12,543 Cr₹12,222 Cr₹13,858 Cr₹12,581 Cr
Total Debt₹1,766 Cr₹0 Cr₹28 Cr₹142 Cr₹16 Cr₹1,793 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹3,906 Cr₹3,974 Cr₹2,140 Cr₹320 Cr₹2,517 Cr₹1,980 Cr
Investing₹-4,172 Cr₹-1,712 Cr₹-1,287 Cr₹1,292 Cr₹-1,240 Cr₹1,107 Cr
Financing₹1,732 Cr₹-2,184 Cr₹-337 Cr₹-1,572 Cr₹-1,885 Cr₹-891 Cr
Free Cash Flow₹3,906 Cr₹3,974 Cr₹2,140 Cr₹-585 Cr₹1,840 Cr₹1,307 Cr
Shareholding
Promoter 46.86% Institutions 47.03% Public 6.11%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search